cefatab
cefatab
Authorised
- Cefalexin monohydrate
Product identification
Medicine name:
cefatab
Cefatab vet flavour 250 mg Tabletten für Hunde und Katzen
Active substance:
- Cefalexin monohydrate
Target species:
-
Dog
-
Cat
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Cefalexin monohydrate262.50/milligram(s)1.00Tablet
Pharmaceutical form:
-
Tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ01DB01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Germany
Available in:
-
Germany
Package description:
- Cardboard box of 9 blisters (Aluminium - PVC /PE /PVDC blister) of 10 tablets
- Cardboard box of 8 blisters (Aluminium - PVC /PE /PVDC blister) of 10 tablets
- Cardboard box of 7 blisters (Aluminium - PVC /PE /PVDC blister) of 10 tablets
- Cardboard box of 6 blisters (Aluminium - PVC /PE /PVDC blister) of 10 tablets
- Cardboard box of 5 blisters (Aluminium - PVC /PE /PVDC blister) of 10 tablets
- Cardboard box of 4 blisters (Aluminium - PVC /PE /PVDC blister) of 10 tablets
- Cardboard box of 3 blisters (Aluminium - PVC/ PE /PVDC blister) of 10 tablets
- Cardboard box of 25 blisters (Aluminium - PVC /PE /PVDC blister) of 10 tablets.
- Cardboard box of 2 blisters (Aluminium - PVC/ PE /PVDC blister) of 10 tablets
- Cardboard box of 10 blisters (Aluminium - PVC /PE /PVDC blister) of 10 tablets. Cardboard box containing 10 separate cardboard boxes, each containing 1 blister of 10 tablet
- Cardboard box of 1 blister (Aluminium - PVC /PE /PVDC blister) of 10 tablets
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
- CP-Pharma Handelsgesellschaft mbH
Marketing authorisation date:
Manufacturing sites for batch release:
- CP-Pharma Handelsgesellschaft mbH
Responsible authority:
- Federal Office Of Consumer Protection And Food Safety
Authorisation number:
- 402586.00.00
Date of authorisation status change:
Reference member state:
-
Netherlands
Procedure number:
- NL/V/0263/002
Concerned member states:
-
Germany
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
German (PDF)
Published on: 19/12/2024
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
German (PDF)
Published on: 19/12/2024